Showing results (21-30 of 31) with videos related to

Sort By:
Pageof 4
Minerva Gastroenterologica E Dietologica|December 3, 2008
Targeted therapy with trastuzumab in dysplasia and adenocarcinoma arising in Barrett's esophagus: a translational approachV Villanacci, E Rossi, S Grisanti, et al.
Cancer Chemotherapy and Pharmacology|January 4, 2008
A multi-centre retrospective review of second-line therapy in advanced pancreatic adenocarcinomaM Reni, R Berardi, A Mambrini, et al.
Breast Cancer Research and Treatment|October 27, 2001
Solitary breast metastases from a renal cell carcinomaL Vassalli, V D Ferrari, E Simoncini, et al.
Journal of the National Cancer Institute|February 16, 1994
Phase III trial of initial chemotherapy in stage III or IV head and neck cancers: a study by the Gruppo di Studio sui Tumori della Testa e del ColloA Paccagnella, A Orlando, C Marchiori, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|November 25, 2003
Carboplatin and teniposide as third-line chemotherapy in patients with recurrent oligodendroglioma or oligoastrocytoma: a phase II studyA A Brandes, U Basso, F Vastola, et al.
AIDS Patient Care and Stds|July 27, 2007
Merkel cell carcinoma and HIV infection: a case report and review of the literatureM A Manganoni, C Farisoglio, G Tucci, et al.
ESMO Open|March 10, 2022
Phase II study of cabazitaxel as second-third line treatment in patients with metastatic adrenocortical carcinomaM Laganà, S Grisanti, R Ambrosini, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|July 1, 1997
A multicentre, randomized, pharmacokinetic, endocrine and clinical study to evaluate formestane in breast cancer patients at first relapse: endocrine and clinical results. The Italian Trials in Medical Oncology (I.T.M.O.) groupE Bajetta, N Zilembo, S Barni, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology|March 5, 2004
A randomized phase II study of combination, alternating and sequential regimens of doxorubicin and docetaxel as first-line chemotherapy for women with metastatic breast cancerS Cresta, G Grasselli, M Mansutti, et al.
British Journal of Cancer|September 8, 2012
Dynamic changes of live/apoptotic circulating tumour cells as predictive marker of response to sunitinib in metastatic renal cancerE Rossi, M Fassan, M Aieta, et al.
Pageof 4